The nations quickest to enact social distancing and contact-tracing systems have mostly kept COVID-19 in check, but their citizens find themselves lagging in receiving the shots needed to finally end a pandemic that has devastated millions of lives.
Governments from Japan and Australia to Hong Kong and South Korea are taking their time before granting regulatory approvals for vaccines, in stark contrast to the Western nations that have rushed to inoculate populations.
That cautious approach might seem strange given the urgency to resume normal life, but low infection rates mean that Asian governments are able to wait to see how the unprecedented vaccination drives play out elsewhere.
Still, the strategy runs the risk of leaving them economically disadvantaged against places that botched containment, but rushed out vaccination.
In New Zealand, which has the top spot on Bloomberg’s COVID Resilience Ranking of major economies that have best fought the pandemic, the main opposition party asked New Zealand Prime Minister Jacinda Ardern to explain why the country “has fallen behind the rest of the world with its vaccine program.”
In South Korea, an editorial in newspaper Hankyoreh said: “We cannot forever ask people to stop their daily lives and endure the economic pain.”
Still, officials are defending their pace as the safer approach, and one that they have earned.
“It’s not a bad thing to sit back a bit and see how others are doing,” said Lam Ching-choi (林正財), a physician and a member of the Executive Council that advises Hong Kong’s leader. “I’m totally sympathetic where they don’t have the luxury and they need to do it in the quickest manner to kill the epidemic.”
Hong Kong, reporting a few dozen COVID-19 cases daily and with a total death toll of 162 since the pandemic began, has yet to approve a single vaccine as it awaits more detailed clinical trial data ahead of a planned vaccination drive to start next month.
Australia, which shut its borders to nonresidents when the pandemic began and has instituted strict lockdowns when cases emerge, expects to approve a vaccine developed by Pfizer and BioNTech by the end of this month and an AstraZeneca vaccine next month, with shots also beginning next month.
By contrast, the US and UK have already administered nearly 14 million shots after expedited approvals last month, while Israel has delivered 2 million doses, or 22 shots per 100 people.
Asian officials and health experts remain anxious because it is the first use of this particular mRNA technology for vaccines, which instructs the body to produce proteins that then develop protective antibodies. It is also the first global vaccination effort undertaken at such great speed.
Although millions have received jabs without incident, there have been some allergic reactions, including anaphylactic shock and incidents like the death of a health worker 16 days after receiving the Pfizer shot, although a link has not been established.
“This extra time will allow those countries to learn from the experience of countries that have commenced distribution,” said Adam Taylor, a virologist at Griffith University in Australia. “The more information you have on the process of distribution and the safety of the vaccines, the more confidence you have in your own rollout. The technology used for the Pfizer and Moderna vaccines has never been used before in humans, and although safety looks good, the more data the better.”
Some countries are concerned that pharmaceutical companies have been granted legal immunity in rushed negotiations.
South Korean Minister of Health Park Neung-hoo said that countries have been forced into “unfair contracts” with these firms due to the “incomprehensible” nature of the pandemic. Seoul plans to administer shots next month.
“It is nearly universal around the world that extensive immunity from liability is being demanded” from the companies, Park said at a news conference, adding that South Korean officials need time to scrutinize safety data closely since companies would not take responsibility for any mishaps.
“Rushing to vaccinate populations before we identify risks is not so necessary for us,” Park said.
Such explanations might not sit well with the citizenry of Asian economies that were hit by the virus before the West, and have therefore spent nearly a full year wearing masks, staying at home and abiding by strict social distancing rules.
“Everyone is trying to survive, and I think they should get the vaccines as soon as possible to the people who are comfortable taking it,” said Aron Harilela, chairman of Harilela Hotels and former chairman of the Hong Kong General Chamber of Commerce. “You can keep on worrying that you make the wrong decision, but the whole world is taking vaccines, because all economies are going to be on their knees if we don’t open up.”
In New Zealand — which closed its border early and snuffed out the virus — the opposition has been critical of the country’s slow vaccination timeline, citing a global resurgence of the virus and the emergence of more transmissible variants. New Zealand’s rollout is slated to begin in the second half of this year.
New Zealand Deputy Prime Minister Grant Robertson denied that the country is merely being “polite,” adding that other countries with rising death tolls have priority.
“We’re doing every single thing that is possible to get the vaccines here as soon as we can,” Robertson told NewstalkZB last week.
Another reason for proceeding slower than desperate Western nations is that they do not want a botched rollout to undermine public confidence in the vaccines, potentially jeopardizing the ability to inoculate a sufficient percentage of the population for herd immunity. That is particularly important among Asian populations where confidence in vaccines is already low.
A World Economic Forum-Ipsos survey on global attitudes towards COVID-19 vaccines found that the percentage of respondents who agreed with taking a vaccine dropped up to 9 percentage points from October to last month in countries including South Korea and Japan, which is posting record numbers of new cases and is slated to start inoculations late next month.
“Governments charging in too early when they buy vaccines at great cost and find they cannot use them meaningfully or they are expired — that could be a disaster,” said Jeremy Lim (林方源), associate professor at the National University of Singapore’s Saw Swee Hock School of Public Health.
Officials have also tried to lower expectations, arguing that rollouts would not immediately allow restrictions to be lifted, as it would take the better part of a year for enough people to be vaccinated for conditions to become safe again. Most public health experts say that about 80 percent of the population needs jabs before anything resembling herd immunity is achieved.
Lim added that there is no point rushing to get to 65 percent of the population, but stumbling along the way and being unable to vaccinate the remaining 15 percent.
“It doesn’t matter how fast you are,” he said. “It’s how strong you finish.”
Because much of what former US president Donald Trump says is unhinged and histrionic, it is tempting to dismiss all of it as bunk. Yet the potential future president has a populist knack for sounding alarums that resonate with the zeitgeist — for example, with growing anxiety about World War III and nuclear Armageddon. “We’re a failing nation,” Trump ranted during his US presidential debate against US Vice President Kamala Harris in one particularly meandering answer (the one that also recycled urban myths about immigrants eating cats). “And what, what’s going on here, you’re going to end up in World War
Earlier this month in Newsweek, President William Lai (賴清德) challenged the People’s Republic of China (PRC) to retake the territories lost to Russia in the 19th century rather than invade Taiwan. He stated: “If it is for the sake of territorial integrity, why doesn’t [the PRC] take back the lands occupied by Russia that were signed over in the treaty of Aigun?” This was a brilliant political move to finally state openly what many Chinese in both China and Taiwan have long been thinking about the lost territories in the Russian far east: The Russian far east should be “theirs.” Granted, Lai issued
On Tuesday, President William Lai (賴清德) met with a delegation from the Hoover Institution, a think tank based at Stanford University in California, to discuss strengthening US-Taiwan relations and enhancing peace and stability in the region. The delegation was led by James Ellis Jr, co-chair of the institution’s Taiwan in the Indo-Pacific Region project and former commander of the US Strategic Command. It also included former Australian minister for foreign affairs Marise Payne, influential US academics and other former policymakers. Think tank diplomacy is an important component of Taiwan’s efforts to maintain high-level dialogue with other nations with which it does
On Sept. 2, Elbridge Colby, former deputy assistant secretary of defense for strategy and force development, wrote an article for the Wall Street Journal called “The US and Taiwan Must Change Course” that defends his position that the US and Taiwan are not doing enough to deter the People’s Republic of China (PRC) from taking Taiwan. Colby is correct, of course: the US and Taiwan need to do a lot more or the PRC will invade Taiwan like Russia did against Ukraine. The US and Taiwan have failed to prepare properly to deter war. The blame must fall on politicians and policymakers